Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial

Authors:

Abstract
No abstract available
Funding Information
  • Shanghai Rising-Star Program (23YF1406700)
  • National Natural Science Foundation of China (82003033)
  • National Natural Science Foundation of China (81872454)
  • National Natural Science Foundation of China (U22A20326)

This publication has 29 references indexed in Scilit: